Effect of osteoblast-targeted expression of Bcl-2 in bone: Differential response in male and female mice

Journal of Bone and Mineral Research

Volumn 20, Issue 8, 2005, Pages 1414-1429

  Pantschenko, Alexander G ^a   Zhang, Wenjian ^a   Nahounou, Marcia ^a   McCarthy, Mary Beth ^a   Stover, Mary Louise ^a   Lichtler, Alexander C ^a   Clark, Stephen H ^a   Gronowicz, Gloria A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Apoptosis; Bcl 2; Gender; Osteoblast; Sex; Transgenic mouse

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; ESTROGEN; GLUCOCORTICOID; PROTEIN BCL 2;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE MINERALIZATION; BONE TURNOVER; CELL PROLIFERATION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CELL PROLIFERATION; DENSITOMETRY, X-RAY; ESTROGENS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOPOROSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SEX FACTORS; TRANSGENES;

EID: 22744437071     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050315     Document Type: Article

References (47)

1. Adams JM, Cory S 2001 Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61-66.
2. Antonsson B, Martinou JC 2000 The Bcl-2 protein family. Exp Cell Res 256:50-57.
3. Desagher S, Martinou JC 2000 Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369-377.
4. Gross A 2001 BCL-2 proteins: Regulators of the mitochondrial apoptotic program. IUBMB Life 52:231-236.
5. Lagasse E, Weissman IL 1997 Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021-1031.
6. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Joaquin H 1994 Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030.
7. Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O 1995 bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA 92:4397-4401.
8. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A 1996 Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2:80-86.
9. Nilsen J, Diaz Brinton R 2003 Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA 100:2842-2847.
10. Bhavnani BR 2003 Estrogens and menopause: Pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol 85:473-482.
11. Perillo B, Sasso A, Abbondanza C, Palumbo G 2000 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20:2890-2901.
12. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S 1999 Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem 274:32099-32107.
13. Schorr K, Li M, Krajewski S, Reed JC, Furth PA 1999 Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia 4:153-164.
14. Razandi M, Pedram A, Levin ER 2000 Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14:1434-1447.
15. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ 1993 Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
16. Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY 1994 Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700-3704.
17. Michaelidis TM, Sendtner M, Cooper JD, Airaksinen MS, Holtmann B, Meyer M, Thoenen H 1996 Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 17:75-89.
18. Boot-Handford RP, Michaelidis TM, Hillarby MC, Zambelli A, Denton J, Hoyland JA, Freemont AJ, Grant ME, Wallis GA 1998 The bcl-2 knockout mouse exhibits marked changes in osteoblast phenotype and collagen deposition in bone as well as a mild growth plate phenotype. Int J Exp Pathol 79:329-335.
19. Gohel A, McCarthy MB, Gronowicz G 1999 Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140:5339-5347.
20. Cleary ML, Smith SD, Sklar J 1986 Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28.
21. Lichtler A, Stover ML, Angilly J, Kream B, Rowe DW 1989 Isolation and characterization of the rat alpha 1(I) collagen promoter. Regulation by 1,25-dihydroxyvitamin D. J Biol Chem 264:3072-3077.
22. Lichtler A, Stover ML, Angilly J, Kream B, Rowe DW 1994 Isolation and characterization of the rat alpha 1(I) collagen promoter. Regulation by vitamin D. J Biol Chem 269:16518.
23. Krebsbach PH, Harrison JR, Lichtler AC, Woody CO, Rowe DW, Kream BE 1993 Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: Differential utilization of promoter elements in vivo and in cultured cells. Mol Cell Biol 13:5168-5174.
24. Kalajzic Z, Liu P, Kalajzic I, Du Z, Braut A, Mina M, Canalis E, Rowe DW 2002 Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: Comparison between rat type I collagen and rat osteocalcin promoters. Bone 31:654-660.
25. Visnjic D, Kalajzic I, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, Rowe DW 2001 Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res 16:2222-2231.
26. Singh I 1969 A modification of the Masson-trichrome stain. Indian J Pathol Bacteriol 12:172-173.
27. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
28. Wong GL, Cohn DV 1975 Target cells in bone for parathormone and calcitonin are different: Enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc Natl Acad Sci USA 72:3167-3171.
29. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ 1996 Genetic variability in adult bone density among inbred strains of mice. Bone 18:397-403.
30. Pavlin D, Bedalov A, Kronenberg MS, Kream BE, Rowe DW, Smith CL, Pike JW, Lichtler AC 1994 Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin DS-mediated transcriptional repression in osteoblastic cells. J Cell Biochem 56:490-501.
31. Bogdanovic Z, Bedalov A, Krebsbach PH, Pavlin D, Woody CO, Clark SH, Thomas HF, Rowe DW, Kream BE, Lichtler AC 1994 Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res 9:285-292.
32. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA 1998 Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissue Int 62:74-82.
33. Stover ML, Wang CK, McKinstry MB, Kalajzic I, Gronowicz G, Clark SH, Rowe DW, Lichtler AC 2001 Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice. Mol Ther 3:543-550.
34. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D 2002 Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15-25.
35. Borner C 1996 Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem 271:12695-12698.
36. Limana F, Urbanek K, Chimenti S, Quaini F, Leri A, Kajstura J, Nadal-Ginard B, Izumo S, Anversa P 2002 bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 99:6257-6262.
37. Linette GP, Korsmeyer SJ 1994 Differentiation and cell death: Lessons from the immune system. Curr Opin Cell Biol 6:809-815.
38. Lynch MP, Capparelli C, Stein JL, Stein GS, Lian JB 1998 Apoptosis during bone-like tissue development in vitro. J Cell Biochem 68:31-49.
39. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC 1998 Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines. J Bone Miner Res 13:793-802.
40. Weinstein RS, Manolagas SC 2000 Apoptosis and osteoporosis. Am J Med 108:153-164.
41. Manolagas SC 2000 Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137.
42. Gronowicz G, Woodiel FN, McCarthy MB, Raisz LG 1989 In vitro mineralization of fetal rat parietal bones in defined serum-free medium: Effect of beta-glycerol phosphate. J Bone Miner Res 4:313-324.
43. Dubai DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM 1999 Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. J Neurosci 19:6385-6393.
44. Bynoe MS, Grimaldi CM, Diamond B 2000 Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci USA 97:2703-2708.
45. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104:719-730.
46. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409.
47. Vanderschueren D, van Herck E, Nijs J, Ederveen AG, De Coster R, Bouillon R 1997 Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 138:2301-2307.